Product Description
Mechanisms of Action: PDE5 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Brazil | Dominican Republic | Mexico
Approved Indications: None
Known Adverse Events: None
Company: Cristália Produtos Químicos Farmacêuticos
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: